KFI
LUMO

Key Financial Inc’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Key Financial Inc’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,927
Closed -$42.3K – 1409
2024
Q3 		$42.3K Hold
10,927
– – 0.01% 505
2024
Q2 		$25.4K Hold
10,927
– – 0.01% 593
2024
Q1 		$30.8K Hold
10,927
– – 0.01% 525
2023
Q4 		$34.7K Hold
10,927
– – 0.01% 486
2023
Q3 		$36.1K Hold
10,927
– – 0.01% 457
2023
Q2 		$36.1K Hold
10,927
– – 0.01% 460
2023
Q1 		$36.2K Hold
10,927
– – 0.01% 445
2022
Q4 		$96.7K Hold
10,927
– – 0.05% 246
2022
Q3 		$97K Buy
10,927
+11
+0.1% +$91 0.05% 250
2022
Q2 		$84K Buy
+10,916
New +$87.3K 0.05% 275

Key Financial Inc's LUMO Position: Q4 2024 in Review

Key Financial Inc sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2024, closing a stake of 10,927 shares — an estimated $42.3K sold.

Key Financial Inc first reported a position in LUMO in Q2 2022 and held it in 10 quarters. The position peaked at $97K in Q3 2022. 0 funds tracked by Wall St. Rank hold LUMO as of Q4 2024.

  • Key Financial Inc reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Key Financial Inc sold 10,927 Lumos Pharma, Inc. Common Stock shares in Q4 2024, an estimated $42.3K.
  • Key Financial Inc first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2022 and held it in 10 quarters.
  • Key Financial Inc's Lumos Pharma, Inc. Common Stock position peaked at $97K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2024.

Based on Key Financial Inc's 13F filing for Q4 2024, filed 31 Jan 2025.